Go Deep
Biodesix, Inc.
Biodesix, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 154 | -7.7 | 27.68 | 7.85 | 2,277.79 |
| Oct 2026 | -375 | -8.3 | 28.51 | 7.85 | 2,346.49 |
| Oct 2026 | 396 | -7.6 | 27.30 | 7.85 | 2,240.96 |
| Oct 2026 | 586 | -7.5 | 27.00 | 7.85 | 2,218.70 |
| Oct 2026 | 242 | -7.7 | 27.54 | 7.85 | 2,263.27 |
| Oct 2026 | 198 | -7.7 | 27.61 | 7.85 | 2,263.35 |
| Oct 2026 | 190 | -7.7 | 27.62 | 7.85 | 2,259.72 |
Biodesix, Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 26,861,000.0 | 25,555,000.0 | 28,755,000.0 | 21,768,000.0 |
| Net Profit | -7,273,000.0 | -7,793,000.0 | -3,980,000.0 | -8,716,000.0 |
| EPS | -0.7 | -0.8 | -0.5 | -1.2 |
Biodesix, Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 88,499,000.0 | 71,323,000.0 | 49,087,000.0 | 38,212,000.0 | — |
| Net Profit | -35,265,000.0 | -42,931,000.0 | -52,146,000.0 | -65,447,000.0 | — |
| EPS | -4.7 | -6.6 | -12.8 | -31.0 | — |
Biodesix, Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Total Assets | 87,476,000.0 | 97,244,000.0 | 99,096,000.0 | 92,906,000.0 |
| Total Liabilities | 89,941,000.0 | 76,368,000.0 | 94,516,000.0 | 72,300,000.0 |
| Total Equity | -2,465,000.0 | 20,876,000.0 | 4,580,000.0 | 20,606,000.0 |
Owes vs Owns
Biodesix, Inc. owed $0.90 for every $1 it owned in Jun 2026, up from $0.78 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.90× | 1.03× | 0.79× | 0.95× | 0.78× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Biodesix, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 21.7%Receivables 10.3%Fixed assets (tangible) 31.8%Intangible assets 21.6%Other assets 14.5%
How it's funded — Dec 2025
Long-term debt 52.8%Payables 3.4%Other liabilities 43.8%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 19.0 | 26.2 | 26.3 | 43.1 |
| Receivables | 9.0 | 8.6 | 7.7 | 5.1 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 27.8 | 29.6 | 29.6 | 8.8 |
| Intangible assets | 18.9 | 20.9 | 22.9 | 24.8 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 12.7 | 11.9 | 12.6 | 11.1 |
| Liabilities & equity | ||||
| Short-term debt | 0.0 | 0.0 | 0.1 | 0.0 |
| Long-term debt | 47.4 | 36.4 | 35.2 | 25.0 |
| Payables | 3.1 | 2.2 | 2.9 | 1.7 |
| Other liabilities | 39.4 | 37.7 | 56.3 | 45.6 |
| Shareholders' equity | -2.5 | 20.9 | 4.6 | 20.6 |
| Net tangible assets | -21.4 | -0.0 | -18.4 | -4.2 |
Biodesix, Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -23,271,000.0 | -48,649,000.0 | -22,870,000.0 | -44,972,000.0 | — |
| Investing Activities | -403,000.0 | -3,440,000.0 | -23,062,000.0 | -3,534,000.0 | — |
| Financing Activities | 16,417,000.0 | 52,050,000.0 | 29,129,000.0 | 58,882,000.0 | — |